Troy Bemis, PhD, is currently a Scientist III in Medicinal Chemistry at Arrowhead Pharmaceuticals, focusing on discovery chemistry and biotech applications. Troy earned a Doctor of Philosophy in Organic Chemistry from UC San Diego, where research primarily centered on targeted protein degradation and small-molecule design. Prior experience includes roles as an Equity Research Associate at ROTH Capital Partners and Capital One Securities, and as a Laboratory Technician at Brenntag. Troy's work has been published in prominent journals, contributing to advancements in medicinal chemistry and pharmacological modalities.
Location
Madison, United States